Morning Market Movers

shares climbed 50.92% to $9.33 on Phase IIa Parkinson's treatment study results.

jumped 23.38% to $3.22 on report of possible legalization of online prescription drug sales in China.

shares gained 15.94% to $1.60 after the company announced a $5 million share repurchase program.

shares surged 8.22% to $9.00 following positive comments from RBC's Michael Yee.

shares rose 7.67% to $9.13 following the disclosure of a 7.1% stake by Corvex and confirmation of discussions with the company.

shares climbed 6.87% to $7.78. Analysts at Morgan Stanley initiated coverage on shares of Cnova with a Overweight rating. Bank of America initiated coverage on Cnova with a Buy rating. JP Morgan initiated coverage on Cnova with a Overweight rating.

shares gained 3.61% to $10.05. Repros Therapeutics initiated two Phase 2B uterine fibroid studies. The company is expecting dossier to be filed by end of first quarter.

gained 1.95% to $5.22 after the company reported that it has received a $40 million in satellite communication system, earth station and ground equipment contract awards.